Alisa Lask
CIK: 0001767593
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Lask Alisa
Lask Alisa (SEC CIK 0001767593) files insider reports with the SEC as Director of CollPlant Biotechnologies Ltd (CLGN) and Director of NEPHROS INC (NEPH).
Signal8 holds 2 ownership filings by Lask Alisa (1 Form 3, 1 Form 4), filed between Jan 3, 2025 and Mar 18, 2026. Those filings report 1 transaction, the latest on Jan 1, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Lask Alisa's filings is in SOUTH ORANGE, NJ.
Recent filings by Lask Alisa
- Jan 1, 2025: Grant or award of NEPH derivative securities (Form 4, code A).
Other insiders filing for CollPlant Biotechnologies Ltd (CLGN)
- Shlomi Ruty Ben, Director
- Rotem Eran, Deputy CEO and CFO
- Abelis Bar Berta, VP Legal
- Evans Hugh M, Director
- Tal Yehiel, Chief Executive Officer
- Penn Elan, Director